DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Olfactory transduction	R-HSA-9751605	map04740	cotinine	5337997	drug-path
Axon guidance	R-HSA-422475	map04360	cotinine	5337997	drug-path
Parkinson's disease	R-HSA-1643685	0	cotinine	5337997	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	cotinine	5337997	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	cotinine	5337997	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	cotinine	5337997	drug-path
Tight junction	R-HSA-2134514	map04530	cotinine	5337997	drug-path
Allograft rejection	R-HSA-9679028	map05330	cotinine	5337997	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	cotinine	5337997	drug-path
Shigellosis	0	map05131	erythromycin	3913	drug-path
Pathogenic Escherichia coli infection	R-HSA-9609646	map05130	erythromycin	3913	drug-path
Glioma	Q9NZM4	map05214	amoxapine	2170	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	amoxapine	2170	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	amoxapine	2170	drug-path
B cell receptor signaling pathway	R-HSA-983705	map04662	amoxapine	2170	drug-path
T cell receptor signaling pathway	R-HSA-983705	map04660	amoxapine	2170	drug-path
Leukocyte transendothelial migration	R-HSA-8950732	map04670	amoxapine	2170	drug-path
Insulin signaling pathway	R-HSA-74752	map04910	amoxapine	2170	drug-path
Amyotrophic lateral sclerosis (ALS)	Q8NDH6-2	0	amoxapine	2170	drug-path
Pancreatic cancer	R-HSA-9700206	map05212	amoxapine	2170	drug-path